Notably, patient clustering by these biomarkers in combination with cytoplasmic Kaiso expression identifies multiple breast cancer groups (A1-C2) with distinct survival differences (Fig. 3b and Supplementary Fig. 5). The gene discussed is ZBTB33; the disease is breast carcinoma.